China Mengniu Dairy Company (2319) H1 2024 earnings summary

Executive summary

• Revenue for H1 2024 was RMB44,670.5 million, down 12.6% year-over-year due to weak demand and industry oversupply.

• Net profit attributable to shareholders fell 19% to RMB2,445.8 million, impacted by inventory losses and JV/affiliate losses.

• Gross profit margin improved by 1.9 percentage points to 40.3%, and operating margin rose to 7.0% through efficiency measures.

• The company maintained leadership in key segments and continued to focus on innovation, digital transformation, and international expansion.

• Share repurchase plan of up to HK$2 billion was announced for the next 12 months.

Financial highlights

• EBITDA was RMB4,790.8 million, down 7.5% year-over-year, with margin up to 10.7%.

• Basic EPS dropped 18.6% to RMB0.623.

• Net cash inflow from operating activities was RMB1,919.9 million, down 44.4% year-over-year.

• Capital expenditure for H1 2024 was RMB1,692.9 million, with full-year CapEx expected below RMB3 billion.

• Debt-to-equity ratio increased to 81.3% from 73.9% at year-end 2023.

Outlook and guidance

• Management expects macroeconomic recovery and rising health awareness to drive demand for premium and diversified dairy products.

• Focus remains on R&D, innovation, brand building, digitization, and channel optimization.

• Continued emphasis on high-quality growth, product mix refinement, and balanced business expansion.

• Plans to alleviate industry demand-supply imbalances and drive category innovation.

• Dividend payouts are set to rise, with a share buyback program authorized.